These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 37522912)
41. Pathogenesis-directed therapy of 2019 novel coronavirus disease. Stratton CW; Tang YW; Lu H J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355 [TBL] [Abstract][Full Text] [Related]
42. Post-Covid-19 Syndrome: Improvements in Health-Related Quality of Life Following Psychology-Led Interdisciplinary Virtual Rehabilitation. Harenwall S; Heywood-Everett S; Henderson R; Godsell S; Jordan S; Moore A; Philpot U; Shepherd K; Smith J; Bland AR J Prim Care Community Health; 2021; 12():21501319211067674. PubMed ID: 34939506 [TBL] [Abstract][Full Text] [Related]
43. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. Daugherty SE; Guo Y; Heath K; Dasmariñas MC; Jubilo KG; Samranvedhya J; Lipsitch M; Cohen K BMJ; 2021 May; 373():n1098. PubMed ID: 34011492 [TBL] [Abstract][Full Text] [Related]
44. [COVID-19 as an insurance case of the statutory accident insurance: occupational disease or occupational accident : Relevant knowledge for the (general and abdominal) surgeon]. Böckelmann I; Meyer F; Thielmann B Chirurgie (Heidelb); 2023 Aug; 94(8):703-713. PubMed ID: 37266705 [TBL] [Abstract][Full Text] [Related]
45. [COVID-19 and work environment: legislative developments about the role of the occupational physician in the emergency management and in the SARS-CoV-2-related work accidents notification]. Garzaro G; Declementi M; Frammartino R; Godono A; Ihab M; De Piano ML; Ciocan C; Bergamaschi E G Ital Med Lav Ergon; 2020 Sep; 42(3):195-200. PubMed ID: 33119980 [TBL] [Abstract][Full Text] [Related]
46. Occupational Therapy in Postacute Care for Survivors of COVID-19: Research Gaps We Need to Fill. Malcolm MP Am J Occup Ther; 2021; 75(Supplement_1):7511347020p1-7511347020p5. PubMed ID: 34405801 [TBL] [Abstract][Full Text] [Related]
47. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Horn A; Krist L; Lieb W; Montellano FA; Kohls M; Haas K; Gelbrich G; Bolay-Gehrig SJ; Morbach C; Reese JP; Störk S; Fricke J; Zoller T; Schmidt S; Triller P; Kretzler L; Rönnefarth M; Von Kalle C; Willich SN; Kurth F; Steinbeis F; Witzenrath M; Bahmer T; Hermes A; Krawczak M; Reinke L; Maetzler C; Franzenburg J; Enderle J; Flinspach A; Vehreschild J; Schons M; Illig T; Anton G; Ungethüm K; Finkenberg BC; Gehrig MT; Savaskan N; Heuschmann PU; Keil T; Schreiber S Infection; 2021 Dec; 49(6):1277-1287. PubMed ID: 34642875 [TBL] [Abstract][Full Text] [Related]
48. Community-Based Primary Care Management for an Older Adult With COVID-19: A Case Report. Sclarsky H; Kumar P Am J Occup Ther; 2021; 75(Supplement_1):7511210030p1-7511210030p7. PubMed ID: 34405796 [TBL] [Abstract][Full Text] [Related]
49. A longitudinal SARS-CoV-2 biorepository for COVID-19 survivors with and without post-acute sequelae. LaVergne SM; Stromberg S; Baxter BA; Webb TL; Dutt TS; Berry K; Tipton M; Haberman J; Massey BR; McFann K; Alnachoukati O; Zier L; Heacock T; Ebel GD; Henao-Tamayo M; Dunn J; Ryan EP BMC Infect Dis; 2021 Jul; 21(1):677. PubMed ID: 34256735 [TBL] [Abstract][Full Text] [Related]
50. Lessons Learned From the COVID-19 Pandemic: Occupational Therapy on the Front Line. Robinson MR; Koverman B; Becker C; Ciancio KE; Fisher G; Saake S Am J Occup Ther; 2021; 75(2):7502090010p1-7502090010p7. PubMed ID: 33657341 [TBL] [Abstract][Full Text] [Related]
51. Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version). Jin YH; Zhan QY; Peng ZY; Ren XQ; Yin XT; Cai L; Yuan YF; Yue JR; Zhang XC; Yang QW; Ji J; Xia J; Li YR; Zhou FX; Gao YD; Yu Z; Xu F; Tu ML; Tan LM; Yang M; Chen F; Zhang XJ; Zeng M; Zhu Y; Liu XC; Yang J; Zhao DC; Ding YF; Hou N; Wang FB; Chen H; Zhang YG; Li W; Chen W; Shi YX; Yang XZ; Wang XJ; Zhong YJ; Zhao MJ; Li BH; Ma LL; Zi H; Wang N; Wang YY; Yu SF; Li LY; Huang Q; Weng H; Ren XY; Luo LS; Fan MR; Huang D; Xue HY; Yu LX; Gao JP; Deng T; Zeng XT; Li HJ; Cheng ZS; Yao X; Wang XH; ; Mil Med Res; 2020 Sep; 7(1):41. PubMed ID: 32887670 [TBL] [Abstract][Full Text] [Related]
52. Occupational Therapy's Role in Addressing the Psychological and Social Impact of COVID-19. Lannigan EG; Tyminski Q Am J Occup Ther; 2021; 75(Supplement_1):7511347030p1-7511347030p7. PubMed ID: 34405802 [TBL] [Abstract][Full Text] [Related]
53. The change in occupational participation and quality of life following occupational therapy for people supervised by probation. Yaran M; Kayihan H Aust Occup Ther J; 2023 Oct; 70(5):559-569. PubMed ID: 37217454 [TBL] [Abstract][Full Text] [Related]
54. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study. Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796 [TBL] [Abstract][Full Text] [Related]
55. Long-term health consequences among individuals with SARS-CoV-2 infection compared to individuals without infection: results of the population-based cohort study CoMoLo Follow-up. Heidemann C; Sarganas G; Du Y; Gaertner B; Poethko-Müller C; Cohrdes C; Schmidt S; Schlaud M; Scheidt-Nave C BMC Public Health; 2023 Aug; 23(1):1587. PubMed ID: 37605232 [TBL] [Abstract][Full Text] [Related]
56. Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. Schultheiß C; Willscher E; Paschold L; Gottschick C; Klee B; Bosurgi L; Dutzmann J; Sedding D; Frese T; Girndt M; Höll JI; Gekle M; Mikolajczyk R; Binder M J Med Virol; 2023 Jan; 95(1):e28364. PubMed ID: 36458566 [TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial. Olagunju A; Fowotade A; Olagunoye A; Ojo TO; Adefuye BO; Fagbamigbe AF; Adebiyi AO; Olagunju OI; Ladipo OT; Akinloye A; Adeagbo BA; Onayade A; Bolaji OO; Happi C; Rannard S; Owen A Trials; 2021 Jan; 22(1):3. PubMed ID: 33397457 [TBL] [Abstract][Full Text] [Related]
58. A pilot study of therapeutic plasma exchange for serious SARS CoV-2 disease (COVID-19): A structured summary of a randomized controlled trial study protocol. Faqihi F; Alharthy A; Alodat M; Asad D; Aletreby W; Kutsogiannis DJ; Brindley PG; Karakitsos D Trials; 2020 Jun; 21(1):506. PubMed ID: 32513290 [TBL] [Abstract][Full Text] [Related]
59. Relevance, resilience, and ageism: A bright future for occupational therapy and healthy ageing, Sylvia Docker Lecture 2021. Clemson L Aust Occup Ther J; 2022 Feb; 69(1):3-14. PubMed ID: 34988989 [TBL] [Abstract][Full Text] [Related]
60. Current Practice in Occupational Therapy for COVID-19 and Post-COVID-19 Conditions. von Zweck C; Naidoo D; Govender P; Ledgerd R Occup Ther Int; 2023; 2023():5886581. PubMed ID: 37250066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]